Cognitive heterogeneity in schizophrenia

Current Opinion in Psychiatry

Volumn 20, Issue 3, 2007, Pages 268-272

  Joyce, Eileen M ^a,b   Roiser, Jonathan P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cognition; IQ; Polymorphisms; Schizophrenia; Working memory

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE;

COGNITIVE DEFECT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTELLIGENCE QUOTIENT; MEMORY DISORDER; NEUROANATOMY; NEUROBIOLOGY; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WORKING MEMORY;

EID: 34247135843     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3280ba4975     Document Type: Review

References (49)

1. Nuechterlein KH, Barch DM, Gold JM, et al. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72:29-39.
2. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636-645.
3. Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007; 33:21-32.
4. Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 2006; 59:929-939.
5. Goldstein G. Neuropsychological heterogeneity in schizophrenia: a consideration of abstraction and problem-solving abilities. Arch Clin Neuropsychol 1990; 5:251-264.
6. Heinrichs RW, Awad AG. Neurocognitive subtypes of chronic schizophrenia. Schizophr Res 1993; 9:49-58.
7. Palmer BW, Heaton RK, Paulsen JS, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997; 11:437-446.
8. Holthausen EA, Wiersma D, Sitskoorn MM, et al. Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation? Psychiatry Res 2002; 112:1-11.
9. Kremen WS, Seidman LJ, Faraone SV, et al. The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol 2000; 109:743-752.
10. Kremen WS, Seidman LJ, Faraone SV, et al. Heterogeneity of schizophrenia: a study of individual neuropsychological profiles. Schizophr Res 2004; 71:307-321.
11. Kremen WS, Seidman LJ, Faraone SV, Tsuang MT. Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers. Biol Psychiatry 2001; 50:453-462.
12. Allen DN, Goldstein G, Warnick E. A consideration of neuropsychologically normal schizophrenia. J Int Neuropsychol Soc 2003; 9:56-63.
13. Horan WP, Goldstein G. A retrospective study of premorbid ability and aging differences in cognitive clusters of schizophrenia. Psychiatry Res 2003; 118:209-221.
14. Wilk CM, Gold JM, McMahon RP, et al. No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology 2005; 19:778-786.
15. Joyce EM, Hutton SB, Mutsatsa SH, Barnes TR. Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry 2005; 187:516-522.
16. Goldstein G, Allen DN, Seaton BE. A comparison of clustering solutions for cognitive heterogeneity in schizophrenia. J Int Neuropsychol Soc 1998; 4: 353-362.
17. Goldstein G, Shemansky WJ. Influences on cognitive heterogeneity in schizophrenia. Schizophr Res 1995; 18:59-69.
18. Heinrichs RW, Ruttan L, Zakzanis KK, Case D. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity. Brain Cogn 1997; 35:207-224.
19. Weickert TW, Goldberg TE, Gold JM, et al. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 2000; 57:907-913.
20. Paulsen JS, Heaton RK, Sadek JR, et al. The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc 1995; 1:88-99.
21. Turetsky BI, Moberg PJ, Mozley LH, et al. Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology 2002; 16:481-490.
22. Vaz SM, Heinrichs RW. Stability and validity of memory-based subtypes of schizophrenia. J Int Neuropsychol Soc 2006; 12:782-791. This study fully explores the typology of memory deficits in schizophrenia and suggests that a more simple classification (impaired/unimpaired) fitted the data best. It showed that even this classification had only moderate stability over time, however.
23. van Winkel R, Myin-Germeys I, Delespaul P, et al. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: A 10-year follow-up study. Schizophr Res 2006; 88:47-54.
24. Dickinson D, Iannone VN, Wilk CM, Gold JM. General and specific cognitive deficits in schizophrenia. Biol Psychiatry 2004; 55:826-833.
25. Dickinson D, Ragland JD, Calkins ME, et al. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophr Res 2006; 85:20-29. This study grapples with the concept of specific cognitive impairments in schizophrenia with the use of sophisticated statistical analysis of multiple neuropsychological variables in schizophrenia and healthy controls. Both groups showed the same hierarchical structure whereby performance in different cognitive domains can be substantially explained by a single general ability factor.
26. Hallmayer JF, Kalaydjieva L, Badcock J, et al. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet 2005; 77:468-476.
27. Hallmayer JF, Jablensky A, Michie P, et al. Linkage analysis of candidate regions using a composite neurocognitive phenotype correlated with schizophrenia. Mol Psychiatry 2003; 8:511-523.
28. Straub RE, MacLean CJ, Ma Y, et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 2002; 7:542-559.
29. Donohoe G, Morris DW, Clarke S, et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study. Neuropsychologia 2007; 45:454-458.
30. Burdick KE, Goldberg TE, Funke B, et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res 2007; 89:169-172.
31. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98:6917-6922.
32. Woodward ND, Jayathilake K, Meltzer HY. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr Res 2006 Nov 21 (Epub ahead of print)
33. Bilder RM, Volavka J, Czobor P, et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002; 52:701-707.
34. Mata I, Arranz MJ, Staddon S, et al. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis. Psychiatr Genet 2006; 16:213-216.
35. Golimbet V, Gritsenko I, Alfimova M, et al. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J Biol Psychiatry 2006; 7:238-245.
36. Szoke A, Schurhoff F, Meary A, et al. Lack of influence of COMT and NET genes variants on executive functions in schizophrenic and bipolar patients, their first-degree relatives and controls. Am J Med Genet B Neuropsychiatr Genet 2006; 141:504-512.
37. Ho BC, Wassink TH, O'Leary DS, et al. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005; 10:229, 287-298.
38. Ohnishi T, Hashimoto R, Mori T, et al. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006; 129 (Pt 2):399-410.
39. Rosa A, Peralta V, Cuesta MJ, et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 2004; 161:1110-1112.
40. Rybakowski JK, Borkowska A, Czerski PM, et al. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET). Psychiatry Res 2006; 143:13-19.
41. Bertolino A, Caforio G, Blasi G, et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 2004; 161:1798-1805.
42. Weickert TW, Goldberg TE, Mishara A, et al. Catechol-O- methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 2004; 56:677-682.
43. Mattay VS, Goldberg TE, Fera F, et al. Catechol O-methyltransferaseval158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003; 100:6186-6191.
44. Rybakowski JK, Borkowska A, Skibinska M, et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci 2006; 60:70-76.
45. Ho BC, Milev P, O'Leary DS, et al. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006; 63:731-740.
46. Burdick KE, Hodgkinson CA, Szeszko PR, et al. DISC1 and neurocognitive function in schizophrenia. Neuroreport 2005; 16:1399-1402.
47. Goldberg TE, Straub RE, Callicott JH, et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006; 31:2022-2032.
48. Agartz I, Sedvall GC, Terenius L, et al. BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006; 141:513-523.
49. Gurling HM, Critchley H, Datta SR, et al. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Arch Gen Psychiatry 2006; 63:844-854.